Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Immunohorizons ; 8(9): 729-739, 2024 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-39330967

RESUMO

Although T cells are encephalitogenic during demyelinating disease, B cell-depleting therapies are a successful treatment for patients with multiple sclerosis. Murine models of demyelinating disease utilizing myelin epitopes, such as myelin oligodendrocyte glycoprotein (MOG)35-55, induce a robust CD4 T cell response but mitigate the contribution of pathological B cells. This limits their efficacy for investigating how B cell depletion affects T cells. Furthermore, induction of experimental autoimmune encephalomyelitis with a single CD4 T cell epitope does not reflect the breadth of epitopes observed in the clinic. To better model the adaptive immune response, mice were immunized with the full-length MOG protein or the MOG1-125 extracellular domain (ECD) and compared with MOG35-55. Mature MOG-reactive B cells were generated only by full-length MOG or ECD. The CNS-localized T cell response induced by full-length MOG is characterized by a reduction in frequency and the percentage of low-affinity T cells with reactivity toward the core epitope of MOG35-55. B cell depletion with anti-CD20 before full-length MOG-induced, but not ECD-induced, demyelinating disease restored T cell reactivity toward the immunodominant epitope of MOG35-55, suggesting the B cell-mediated control of encephalitogenic epitopes. Ultimately, this study reveals that anti-CD20 treatment can influence T cell epitopes found in the CNS during demyelinating disease.


Assuntos
Linfócitos B , Encefalomielite Autoimune Experimental , Glicoproteína Mielina-Oligodendrócito , Glicoproteína Mielina-Oligodendrócito/imunologia , Animais , Camundongos , Linfócitos B/imunologia , Encefalomielite Autoimune Experimental/imunologia , Feminino , Camundongos Endogâmicos C57BL , Linfócitos T CD4-Positivos/imunologia , Epitopos de Linfócito T/imunologia , Fragmentos de Peptídeos/imunologia , Humanos , Modelos Animais de Doenças , Linfócitos T/imunologia
2.
J Immunol ; 211(3): 333-342, 2023 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-37459191

RESUMO

One of the main goals in T cell biology has been to investigate how TCR recognition of peptide:MHC (pMHC) determines T cell phenotype and fate. Ag recognition is required to facilitate survival, expansion, and effector function of T cells. Historically, TCR affinity for pMHC has been used as a predictor for T cell fate and responsiveness, but there have now been several examples of nonfunctional high-affinity clones and low-affinity highly functional clones. Recently, more attention has been paid to the TCR being a mechanoreceptor where the key biophysical determinant is TCR bond lifetime under force. As outlined in this review, the fundamental parameters between the TCR and pMHC that control Ag recognition and T cell triggering are affinity, bond lifetime, and the amount of force at which the peak lifetime occurs.


Assuntos
Receptores de Antígenos de Linfócitos T , Linfócitos T , Receptores de Antígenos de Linfócitos T/metabolismo , Ativação Linfocitária , Células Clonais , Ligação Proteica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA